No, they’re different weekly GLP-1 medicines with different drug ingredients, dose steps, and label details.
Ozempic and Trulicity often show up in the same conversation because they share a lot: both are once-weekly injections, both belong to the GLP-1 receptor agonist class, and both are used for type 2 diabetes. That overlap is real. Still, calling them “the same” can lead to bad assumptions, like thinking doses match across brands or that switching is as simple as grabbing a new pen.
Below, you’ll see what’s shared, where they split, and the practical questions that help you compare them with less stress.
Are Ozempic And Trulicity The Same?
They’re in the same class, but they’re not the same product. Ozempic contains semaglutide. Trulicity contains dulaglutide. Those ingredients aren’t interchangeable, and the FDA labeling for each one has its own dosing tables, device instructions, and wording around benefits and risks.
Both medicines mimic GLP-1 activity in the body. In plain terms, they help the pancreas release insulin when glucose is high, reduce glucagon output, slow stomach emptying, and often curb appetite. That’s why many people see A1C improvement and, for some, weight loss.
What Both Medications Share
When you strip away brand names, the overlap looks like this:
- Weekly dosing: Usually one fixed day each week, with guidance for missed doses in the product instructions.
- Similar early side effects: Stomach upset is common at the start or after dose increases.
- Same class cautions: Low blood sugar risk rises when paired with insulin or a sulfonylurea.
- Boxed warning theme: Both U.S. labels include a thyroid C-cell tumor warning based on rodent studies and list the same core contraindication (MTC or MEN 2).
This shared backbone is why people compare them in the first place. The choice usually comes down to label details, dosing options, and the “feel” of using the device week after week.
Ozempic Vs Trulicity Differences That Affect Daily Use
The biggest divider is the drug ingredient. Different molecules mean you can’t compare milligrams across brands. A “1 mg” dose on one product does not equal “1 mg” on the other. Prescribers treat them as distinct medicines with distinct dose ladders.
Device Steps And User Experience
Both are designed for self-injection under the skin, yet the steps differ by product. Some people care about needle handling, how many steps are involved, and how long the injection takes. Those details can shape comfort, especially for anyone who’s new to injections or gets anxious about the process. If you switch brands, expect a short learning curve even if the schedule stays weekly.
FDA-Approved Label Language Can Differ
In the U.S., the most reliable comparison source is the FDA prescribing information. It spells out what each drug is approved to treat, who it’s meant for, and how dosing is done.
Ozempic’s FDA label covers type 2 diabetes and includes language on cardiovascular risk reduction for certain adults with type 2 diabetes. You can verify the exact wording, dose options, and warnings in the FDA Ozempic prescribing information.
Trulicity’s FDA label covers type 2 diabetes and includes cardiovascular risk-reduction language for certain adults. The official source is the FDA Trulicity prescribing information.
Clinical guidelines evolve as new evidence lands. The American Diabetes Association updates its Standards of Care annually, and the 2025 revisions summarize what changed across diabetes management. ADA 2025 Standards of Care revisions gives a quick view of those updates.
How Dose Step-Up Shapes Tolerance
Most “I can’t handle this” moments happen during dose changes. Both drugs are commonly started at a lower dose and stepped up over weeks. The exact steps and maintenance options differ by product, and that matters because moving up too fast can turn mild nausea into an all-day problem.
If you’re comparing the two, focus less on the brand and more on how the dose ladder fits your life. A slower ramp can be easier to stick with. A higher maintenance option can matter if glucose control is still off target after the starter phase.
Comparison Table: The Fast Side-By-Side View
This table compresses the most searched differences into one place. Confirm details for your exact dose and country, since labeling can vary by region.
| Feature | Ozempic | Trulicity |
|---|---|---|
| Active Ingredient | Semaglutide | Dulaglutide |
| How It’s Taken | Weekly injection under the skin | Weekly injection under the skin |
| Dose Ladder | Step-up schedule and maintenance options per label | Step-up schedule and maintenance options per label |
| Milligram Matching | Not comparable across brands | Not comparable across brands |
| Common Early Side Effects | Nausea, vomiting, diarrhea, constipation | Nausea, vomiting, diarrhea, decreased appetite |
| Low Blood Sugar Risk | Higher when used with insulin or sulfonylureas | Higher when used with insulin or sulfonylureas |
| Boxed Warning Theme | Thyroid C-cell tumor warning on U.S. label | Thyroid C-cell tumor warning on U.S. label |
| Best Source For Exact Details | FDA Ozempic label | FDA Trulicity label |
Side Effects: What’s Common, What’s A Red Flag
GLP-1 medicines often cause stomach-related side effects, especially early on. Slower stomach emptying can make you feel full sooner, which can help appetite. It can also feel like nausea, reflux, bloating, or a heavy stomach after meals.
Many people do better with smaller meals, less greasy food, and slower eating. Hydration can matter a lot if vomiting or diarrhea shows up, since dehydration can strain the kidneys.
Signals You Should Not Brush Off
Some symptoms deserve prompt medical attention, even if you’re hoping they’ll pass. Severe belly pain that doesn’t let up, repeated vomiting with inability to keep fluids down, signs of an allergic reaction, or sudden vision changes are all reasons to seek care quickly. The FDA labels also warn about pancreatitis and gallbladder problems, and they describe symptom patterns to watch for.
The Boxed Warning In Plain Words
Both U.S. labels include a boxed warning about thyroid C-cell tumors seen in rodent studies and advise against use in people with a personal or family history of medullary thyroid carcinoma or MEN 2. For most people, the practical takeaway is screening: your prescriber should ask about that history before starting, and you should report symptoms like a neck lump, hoarseness, trouble swallowing, or shortness of breath.
Choosing Between Them: The Questions That Set You Up Well
People often want a single winner. In real life, the “right” choice depends on goals, tolerance, and access. These questions keep the comparison grounded:
- Is the main goal tighter A1C, weight change, or lowering cardiovascular risk?
- What other glucose-lowering drugs are you taking, and do any raise hypoglycemia risk?
- Have stomach side effects been a dealbreaker with past medications?
- Does your insurance prefer one product, with fewer hoops and lower out-of-pocket cost?
- Will the device steps be manageable for you every week?
Access is often the hidden decider. A medication you can’t get consistently won’t help, even if it looks like the perfect fit on paper.
Switching From One To The Other
Switching can happen because of side effects, cost changes, coverage rules, shortages, or lack of glucose control at the current dose. This is not a self-directed switch. A prescriber usually chooses a starting dose on the new product that fits your current control and your recent medication history, then adjusts over time.
Because both are weekly, calendar timing matters. Many switches are scheduled around the next due injection day, so you avoid double dosing while still keeping glucose stable.
Why The New Starting Dose Can Seem Low
It can feel odd to “start over,” yet it’s often done to reduce side effects. Even if you tolerated one GLP-1 medicine, a new-to-you molecule can trigger nausea during the first weeks. A slower ramp can make the transition easier to live with.
Second Table: Common Symptoms And Practical Moves
Small habits can take the edge off common side effects. This table stays focused on low-risk day-to-day steps. If symptoms are intense or persistent, get medical advice.
| What You Feel | Why It Can Happen | What Often Helps |
|---|---|---|
| Nausea | Stomach emptying slows, especially during dose increases | Smaller meals, bland foods, slow eating, ginger |
| Reflux Or Burping | Food sits longer in the stomach | Earlier dinner, avoid heavy late meals, stay upright after eating |
| Constipation | Gut motility slows and food volume can drop | More water, fiber foods, gentle walking |
| Diarrhea | Gut adjustment during the ramp-up phase | Simple foods, hydration, pause greasy meals |
| Low Appetite | Satiety signaling changes | Protein-first meals, smaller portions more often |
| Injection Site Soreness | Skin irritation or technique | Rotate sites, follow label steps for storage and warming |
| Low Blood Sugar (With Other Drugs) | Insulin or sulfonylureas can drive glucose down | Track glucose, adjust other meds with a clinician |
Key Points To Remember
Ozempic and Trulicity are not the same medication. They share a drug class and weekly dosing, but they use different drug ingredients, different dose ladders, and different device steps. If you’re comparing them, anchor your research to the FDA label for the exact product you’re using, then talk through goals, tolerance, and coverage with your prescribing team.
If you want a patient-friendly overview of semaglutide’s uses and safety themes, MedlinePlus semaglutide injection information is a reliable starting point.
References & Sources
- U.S. Food and Drug Administration (FDA).“Ozempic (semaglutide) Prescribing Information.”Official label covering indications, dosing, contraindications, and major warnings for semaglutide injection.
- U.S. Food and Drug Administration (FDA).“Trulicity (dulaglutide) Prescribing Information.”Official label covering indications, dosing, contraindications, and major warnings for dulaglutide injection.
- American Diabetes Association (ADA).“Summary Of Revisions: Standards of Care in Diabetes—2025.”Annual update summary describing revisions to diabetes care recommendations, including medication-related updates.
- MedlinePlus (U.S. National Library of Medicine).“Semaglutide Injection.”Patient-facing overview of semaglutide injection uses, warnings, and common side effects.